Drugs / Bellafill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01964859 | Jan 2015 → Dec 2027 expected | — | Johns Hopkins University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bellafill | “In some select subjects the investigators will test if the addition of an FDA approved filler product Bellafill might enhance cellular efficacy.” NCT01964859 ↗1“Bellafill” NCT01964859 ↗ |